Results 221 to 230 of about 804,673 (258)

Nuclear receptor drug discovery

Current Opinion in Chemical Biology, 2008
Nuclear receptors (NR) are ligand-activated transcription factors that regulate the activation of a variety of important target genes. There are 48 genes that encode NRs in the human genome, and these receptors now represent one of the most important targets for therapeutic drug development.
openaire   +2 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Nuclear Receptor Coactivators

1999
S, Westin, M G, Rosenfeld, C K, Glass
openaire   +2 more sources

Orphan nuclear receptors

The Journal of Steroid Biochemistry and Molecular Biology, 2012
openaire   +2 more sources

Nuclear Receptors

2010
Neil J. Mckenna, David D. Moore
openaire   +2 more sources

Nuclear Receptors

2022
Sergio C. Chai, Taosheng Chen
openaire   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Nuclear Receptors

2008
Pierre Germain, Hinrich Gronemeyer
openaire   +2 more sources